Fecaal calprotectine
Evidence voor fecaal calprotectine
kinderen in de eerste lijn
Conclusie
Literatuur
- 1.↲Gieteling MJ, Lisman-van Leeuwen Y, Van der Wouden JC, Schellevis FG, Berger MY. Childhood nonspecific abdominal pain in family practice: incidence, associated factors, and management. Ann Fam Med 2011;9:337-43.
- 2.↲Spee LA, Van den Hurk AP, Van Leeuwen Y, Benninga MA, Bierma-Zeinstra SM, Passchier J, et al. Childhood abdominal pain in primary care: design and patient selection of the HONEUR abdominal pain cohort. BMC Fam Pract 2010;11:27.
- 3.↲Berger MY, Gieteling MJ, Benninga MA. Chronic abdominal pain in children. BMJ 2007;334:997-1002.
- 4.↲Van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.
- 5.↲Kok L, Elias SG, Witteman BJ, Goedhard JG, Muris JW, Moons KG, et al. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the cost-effectiveness of a decision rule for abdominal complaints in primary care (CEDAR) Study. Clin Chem 2012;58:989-98.
Reacties
Er zijn nog geen reacties.